📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. (2017)

First Author: Rydzewska LHM

Attributed to: CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2017.07.003

PubMed Identifier: 28800492

Publication URI: http://europepmc.org/abstract/MED/28800492

Type: Journal Article/Review

Volume: 84

Parent Publication: European journal of cancer (Oxford, England : 1990)

ISSN: 0959-8049